Bio Gate AG Stock Deutsche Boerse AG
Equities
DE000BGAG981
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
May. 01 | Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2024 * | 8M 8.57M | Sales 2025 * | 9.6M 10.29M | Capitalization | 9.7M 10.4M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.21 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.3% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Lloret-Grau
CEO | Chief Executive Officer | - | 12-01-07 |
Thomas Konradt
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Volker Rofalski
BRD | Director/Board Member | 54 | 11-12-31 |
Karl Richter
CHM | Chairman | - | - |
Volker Alt
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-6.01% | 180B | |
-0.87% | 107B | |
-4.86% | 67.04B | |
-8.28% | 45.26B | |
+13.07% | 45.73B | |
+6.13% | 41.86B | |
+21.56% | 31.49B | |
+13.61% | 24.77B | |
-4.50% | 24.5B |